The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 28, 2021

Filed:

Nov. 22, 2017
Applicant:

Koninklijke Philips N.v., Eindhoven, NL;

Inventor:

Ronaldus Maria Aarts, Geldrop, NL;

Assignee:

KONINKLIJKE PHILIPS N.V., Eindhoven, NL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 5/05 (2021.01); A61B 5/00 (2006.01); A61B 5/0205 (2006.01); A61B 5/053 (2021.01); A61B 5/11 (2006.01); G16H 50/30 (2018.01); A61B 5/0535 (2021.01); A61B 5/352 (2021.01); A61B 5/021 (2006.01); A61B 5/08 (2006.01);
U.S. Cl.
CPC ...
A61B 5/7275 (2013.01); A61B 5/0205 (2013.01); A61B 5/053 (2013.01); A61B 5/0535 (2013.01); A61B 5/1102 (2013.01); A61B 5/1107 (2013.01); A61B 5/1118 (2013.01); A61B 5/352 (2021.01); A61B 5/681 (2013.01); A61B 5/6825 (2013.01); A61B 5/6829 (2013.01); A61B 5/6887 (2013.01); A61B 5/7282 (2013.01); G16H 50/30 (2018.01); A61B 5/02125 (2013.01); A61B 5/0816 (2013.01); A61B 2562/0252 (2013.01);
Abstract

The invention relates to a determination system () for determining a heart failure risk for a subject (). The determination system is adapted to provide a cardiogram selected from a group consisting of a ballistocardiogram, a seismocardiogram and an impedance cardiogram of the subject, to detect at least one of a presence of a postextrasystolic potentiation (PESP) and a disturbed force-frequency relation (FFR) based on the provided cardiogram and to determine the heart failure risk based on this detection. By using the detection of the presence of the PESP and/or of a disturbed FFR, the heart failure risk can be reliably determined. In particular, it can be determined that the heart failure risk is relatively large, if a PESP is not present and/or if the FFR is disturbed.


Find Patent Forward Citations

Loading…